1. Home
  2. EDSA vs SGMA Comparison

EDSA vs SGMA Comparison

Compare EDSA & SGMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • SGMA
  • Stock Information
  • Founded
  • EDSA 2015
  • SGMA 1993
  • Country
  • EDSA Canada
  • SGMA United States
  • Employees
  • EDSA N/A
  • SGMA N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • SGMA Electrical Products
  • Sector
  • EDSA Health Care
  • SGMA Technology
  • Exchange
  • EDSA Nasdaq
  • SGMA Nasdaq
  • Market Cap
  • EDSA 13.8M
  • SGMA 6.2M
  • IPO Year
  • EDSA N/A
  • SGMA 1994
  • Fundamental
  • Price
  • EDSA $2.09
  • SGMA $3.00
  • Analyst Decision
  • EDSA Strong Buy
  • SGMA
  • Analyst Count
  • EDSA 2
  • SGMA 0
  • Target Price
  • EDSA $13.00
  • SGMA N/A
  • AVG Volume (30 Days)
  • EDSA 13.1K
  • SGMA 65.6K
  • Earning Date
  • EDSA 08-08-2025
  • SGMA 09-02-2025
  • Dividend Yield
  • EDSA N/A
  • SGMA N/A
  • EPS Growth
  • EDSA N/A
  • SGMA N/A
  • EPS
  • EDSA N/A
  • SGMA N/A
  • Revenue
  • EDSA N/A
  • SGMA $311,706,094.00
  • Revenue This Year
  • EDSA N/A
  • SGMA N/A
  • Revenue Next Year
  • EDSA N/A
  • SGMA N/A
  • P/E Ratio
  • EDSA N/A
  • SGMA N/A
  • Revenue Growth
  • EDSA N/A
  • SGMA N/A
  • 52 Week Low
  • EDSA $1.55
  • SGMA $0.96
  • 52 Week High
  • EDSA $5.59
  • SGMA $6.47
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 55.09
  • SGMA 72.43
  • Support Level
  • EDSA $2.03
  • SGMA $2.92
  • Resistance Level
  • EDSA $2.11
  • SGMA $3.00
  • Average True Range (ATR)
  • EDSA 0.10
  • SGMA 0.02
  • MACD
  • EDSA 0.01
  • SGMA -0.04
  • Stochastic Oscillator
  • EDSA 73.33
  • SGMA 100.00

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

Share on Social Networks: